Selected Balance Sheet Information (Details) - USD ($) $ in Thousands |
Jun. 30, 2015 |
Dec. 31, 2014 |
---|---|---|
Other Current Assets [Line Items] | ||
Intrexon prepaid research and development expenses | $ 1,049 | $ 1,067 |
Prepaid Clinical Research Organization expenses | 5,458 | 0 |
Prepaid insurance | 133 | 228 |
Other prepaid expenses | 315 | 253 |
Total | $ 6,955 | $ 1,548 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Sum of the amount paid in advance for clinical research organization. No definition available.
|
X | ||||||||||
- Definition Sum of the amounts paid in advance for research and development expenses. No definition available.
|
X | ||||||||||
- Definition Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|